I understand how this technology could prove useful for monitoring disease progression, but how do they intend to use it as a Covid-19 screen?
It’s not detecting the actual causative agent of disease, only the changes in respiratory airflow. Similar viruses like the common cold and influenza can produce similar upper respiratory tract symptoms. Different strains of Covid produce different symptoms and there’s new strains emerging continually. It’s even possible for Covid-19 to be contagious before the onset of a cough, especially if contracted through food or the eyes. I can’t see this working.
- Forums
- ASX - By Stock
- Ann: ResApp expands COVID-19 clinical program
I understand how this technology could prove useful for...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online